Ontex Group (ONTEX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
Revenue declined 4.9% like-for-like in 2025 to €1,762 million, with adjusted EBITDA margin down 2 percentage points to 10%, mainly due to lower baby care volumes, supply chain constraints, and challenging market conditions.
Free cash flow turned negative at €(25) million, but net debt was reduced by 6% to €577 million, aided by €131 million in divestment proceeds.
Leverage increased to 3.3x from 2.5x in 2024, still below the 3.5x covenant, due to lower EBITDA and reclassification of Algerian cash.
Strategic review initiated and new CEO appointed to sharpen focus, with 2026 priorities set on profit growth, cash generation, and cost transformation.
Financial highlights
Baby care volumes dropped 12%, with retailer brand markets down in Europe and North America due to low consumer confidence, lower birth rates, and intense A-brand promotions.
Adult care volumes grew 1% like-for-like, now representing nearly half of total revenues.
Feminine care volumes declined 2%–2.4%, reflecting market trends.
Adjusted profit from continuing operations was €34 million, down from €76 million in 2024.
Non-cash loss of €190–210 million from divested Brazil and Turkey businesses due to currency translation reserves.
Outlook and guidance
2026 market conditions expected to remain challenging, especially for baby care, with low consumer confidence and continued A-brand promotions.
Adjusted EBITDA targeted to improve by ~10%, with gradual improvement expected from Q2 onwards; Q1 to be in line with Q4 2025.
Free cash flow after financing expected to return to positive territory, and leverage to decrease to 3x or below by year-end.
CapEx guidance remains at 3.5%–4.5% of revenue.
Non-recurring cash outflows expected to be around €20–30 million in 2026, mainly for Belgian footprint restructuring.
Latest events from Ontex Group
- Revenue and EBITDA declined, but adult care grew and net debt was reduced.ONTEX
Q1 202629 Apr 2026 - Strong H1 2024 results and raised outlook as volume growth and cost savings boost profitability.ONTEX
Q2 20242 Feb 2026 - Q3 delivered 29% EBITDA growth, margin gains, and key transformation milestones, with guidance confirmed.ONTEX
Q3 202418 Jan 2026 - Strong volume-driven growth, margin expansion, and lower leverage set the stage for 2025.ONTEX
Q4 202414 Dec 2025 - Q1 2025 margin resilience and strategic actions support a positive 2025 growth outlook.ONTEX
Q1 202528 Nov 2025 - H1 2025 saw revenue and margin declines, but divestments reduced net debt and H2 recovery is expected.ONTEX
Q2 202516 Nov 2025 - H1 2025 saw a 4% revenue and 22% EBITDA drop, but H2 recovery is expected.ONTEX
Q2 2025 TU16 Nov 2025 - Q3 revenue and margin improved sequentially, with guidance and leverage targets reaffirmed.ONTEX
Q3 20254 Nov 2025